These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27713377)

  • 1. Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.
    Bortolato M; Bini V; Tambaro S
    Pharmaceuticals (Basel); 2010 Aug; 3(9):2799-2820. PubMed ID: 27713377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
    Krebs MO; Kebir O; Jay TM
    Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids and Mental Health, Part 1: The Endocannabinoid System and Exogenous Cannabinoids.
    Penn A
    J Psychosoc Nurs Ment Health Serv; 2019 Sep; 57(9):7-10. PubMed ID: 31461513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia].
    Sewell RA; Skosnik PD; Garcia-Sosa I; Ranganathan M; D'Souza DC
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S15-30. PubMed ID: 20512267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Psychiatric Consequences of Cannabinoids.
    De Aquino JP; Sherif M; Radhakrishnan R; Cahill JD; Ranganathan M; D'Souza DC
    Clin Ther; 2018 Sep; 40(9):1448-1456. PubMed ID: 29678279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and the brain.
    Iversen L
    Brain; 2003 Jun; 126(Pt 6):1252-70. PubMed ID: 12764049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cannabis and cannabinoids as drugs].
    Khiabani HZ; Mørland J
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
    Baron EP
    Headache; 2018 Jul; 58(7):1139-1186. PubMed ID: 30152161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
    Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
    Rubino T; Zamberletti E; Parolaro D
    J Psychopharmacol; 2012 Jan; 26(1):177-88. PubMed ID: 21768160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis and mental illness: a review.
    Lowe DJE; Sasiadek JD; Coles AS; George TP
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):107-120. PubMed ID: 30564886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.
    Levine A; Clemenza K; Rynn M; Lieberman J
    J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):214-225. PubMed ID: 28219487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids and Pain: New Insights From Old Molecules.
    Vučković S; Srebro D; Vujović KS; Vučetić Č; Prostran M
    Front Pharmacol; 2018; 9():1259. PubMed ID: 30542280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.
    Haney M; Evins AE
    Neuropsychopharmacology; 2016 Jan; 41(2):393-401. PubMed ID: 26286840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable individual sensitivity to cannabis in patients with schizophrenia.
    Goldberger C; Dervaux A; Gourion D; Bourdel MC; Lôo H; Laqueille X; Krebs MO
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1145-54. PubMed ID: 20529414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and cannabinoid receptors.
    Nocerino E; Amato M; Izzo AA
    Fitoterapia; 2000 Aug; 71 Suppl 1():S6-12. PubMed ID: 10930707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in cannabis research from a pharmaceutical chemist's point of view].
    Müller CE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):818-824. PubMed ID: 31161229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.